There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Pharmacotherapies that augment the incretin pathway have recently become available,
but their role in the management of type 2 diabetes is not well defined.